Popular Articles

Researchers To Inject People With Diabetes With Cells From Pigs
Researchers are hoping that cells from pigs from a remote group of islands 300 miles from New Zealand could lead to a new treatment for Type 1 diabetes.
generic viagra online
Hope For Treatment Of The Metabolic Syndrome Offered By Natural Hormone
Angiotensin 1-7, a hormone in the body that has cardiovascular benefits, improves the metabolic syndrome in rats, according to a new study. The results were presented at The Endocrine Society"s 91st Annual Meeting in Washington, D.C.
News of the day
They Are Young And Need The Job: A Second Chance For Dangerous T Cells
The immune system"s T-cells react to foreign protein fragments and therefore are crucial to combating viruses and bacteria. Errant cells that attack the body"s own material are in most cases driven to cell death. Some of these autoreactive T-cells, however, undergo a kind of reeducation to become "regulatory T-cells" that keep other autoreactive T-cells under control. A group led by immunologist Professor Ludger Klein of LMU Munich has now shown that the developmental stage of an autoreactive T-cell is decisive to its ultimate destiny. Young autoreactive T-cells are very readily reeducated into regulatory T-cells. Under identical conditions, however, older T-cells become fully activated and can cause damage - they are in a way resistant to reeducation. "We now intend to study at the molecular level what makes a T-cell accessible for reeducation," said Klein, "because then it may be possible to convert even normal adult T-cells, which can be obtained easily and in great numbers from blood. Possibly, they could then be used as regulatory T-cells in therapies for autoimmune diseases such as type-1 diabetes or multiple sclerosis: these are diseases that are triggered by uncontrolled autoreactive T-cells." (PNAS, 10 June 2009)
Public Health

90% Of Patients With Charnley Protheses Pain Free After 30 Years

The long term success of the Charnley low-frictional arthroplasty has been demonstrated today with a follow-up study of patients 30 to 40 years after treatment. Overall, 90% of the hips were free from pain and activity was reported as normal in 58% of patients. The 94 patients in the study had a mean age at operation of 43.3 years and a mean age at follow-up of 75.7 years. Therefore some of their reduced activity is a reflection on their age and medical comorbidities. The research demonstrates that the clinical success of the Charnley low-frictional arthroplasty is good and that the "hallmark of that success is freedom from pain". The authors conclude that "the longest follow-up results are in young patients and have been achieved with the earliest design, materials and operative technique". Therefore these results should improve with every generation of arthroplasty with evolutionary development and logical introductions of improvements. Read the full text article. The Journal of Bone and Joint Surgery


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):